Annual Current Liabilities
$17.18 M
+$7.21 M+72.41%
December 1, 2023
Summary
- As of February 25, 2025, RVPH annual total current liabilities is $17.18 million, with the most recent change of +$7.21 million (+72.41%) on December 1, 2023.
- During the last 3 years, RVPH annual current liabilities has risen by +$15.84 million (+1188.74%).
- RVPH annual current liabilities is now at all-time high.
Performance
RVPH Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$17.53 M
+$3.59 M+25.75%
September 1, 2024
Summary
- As of February 25, 2025, RVPH quarterly total current liabilities is $17.53 million, with the most recent change of +$3.59 million (+25.75%) on September 1, 2024.
- Over the past year, RVPH quarterly current liabilities has increased by +$4.50 million (+34.53%).
- RVPH quarterly current liabilities is now at all-time high.
Performance
RVPH Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RVPH Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +72.4% | +34.5% |
3 y3 years | +1188.7% | +90.4% |
5 y5 years | +152.1% | +90.4% |
RVPH Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +632.5% | at high | +647.8% |
5 y | 5-year | at high | +1188.7% | at high | +1939.3% |
alltime | all time | at high | +1188.7% | at high | +1939.3% |
Reviva Pharmaceuticals Holdings Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $17.53 M(+25.7%) |
Jun 2024 | - | $13.94 M(-3.8%) |
Mar 2024 | - | $14.49 M(-15.6%) |
Dec 2023 | $17.18 M(+72.4%) | $17.18 M(+31.8%) |
Sep 2023 | - | $13.03 M(+41.5%) |
Jun 2023 | - | $9.21 M(+40.4%) |
Mar 2023 | - | $6.56 M(-34.1%) |
Dec 2022 | $9.96 M | $9.96 M(+178.6%) |
Sep 2022 | - | $3.58 M(-20.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $4.48 M(+23.6%) |
Mar 2022 | - | $3.62 M(+54.5%) |
Dec 2021 | $2.34 M(+75.9%) | $2.34 M(+140.8%) |
Sep 2021 | - | $973.70 K(-16.3%) |
Jun 2021 | - | $1.16 M(+5.6%) |
Mar 2021 | - | $1.10 M(-17.4%) |
Dec 2020 | $1.33 M(-80.4%) | $1.33 M(+55.0%) |
Nov 2020 | - | $859.80 K |
Dec 2019 | $6.81 M | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual current liabilities year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly current liabilities year-on-year change?
What is Reviva Pharmaceuticals Holdings annual total current liabilities?
The current annual current liabilities of RVPH is $17.18 M
What is the all time high annual current liabilities for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual total current liabilities is $17.18 M
What is Reviva Pharmaceuticals Holdings annual current liabilities year-on-year change?
Over the past year, RVPH annual total current liabilities has changed by +$7.21 M (+72.41%)
What is Reviva Pharmaceuticals Holdings quarterly total current liabilities?
The current quarterly current liabilities of RVPH is $17.53 M
What is the all time high quarterly current liabilities for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly total current liabilities is $17.53 M
What is Reviva Pharmaceuticals Holdings quarterly current liabilities year-on-year change?
Over the past year, RVPH quarterly total current liabilities has changed by +$4.50 M (+34.53%)